AUD 0.03
(-5.71%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 6.24 Million AUD | -20.54% |
2023 | 7.85 Million AUD | 2.64% |
2022 | 7.65 Million AUD | -11.92% |
2021 | 8.69 Million AUD | 52.39% |
2020 | 5.7 Million AUD | -16.08% |
2019 | 6.79 Million AUD | 17.88% |
2018 | 5.76 Million AUD | 3.95% |
2017 | 5.54 Million AUD | 4.33% |
2016 | 5.31 Million AUD | 72.6% |
2015 | 3.08 Million AUD | 115.99% |
2014 | 1.42 Million AUD | 12.28% |
2013 | 1.27 Million AUD | -44.88% |
2012 | 2.3 Million AUD | 8.58% |
2011 | 2.12 Million AUD | -20.82% |
2010 | 2.68 Million AUD | -11.58% |
2009 | 3.03 Million AUD | 36.85% |
2008 | 2.21 Million AUD | -7.16% |
2007 | 2.38 Million AUD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 7.6 Million AUD | 0.0% |
2024 Q4 | 6.24 Million AUD | 0.0% |
2024 FY | 6.24 Million AUD | -20.54% |
2023 Q2 | 7.5 Million AUD | 0.0% |
2023 Q4 | 7.85 Million AUD | 0.0% |
2023 FY | 7.85 Million AUD | 2.64% |
2022 Q2 | 8.57 Million AUD | 0.0% |
2022 Q4 | 7.65 Million AUD | 0.0% |
2022 FY | 7.65 Million AUD | -11.92% |
2021 FY | 8.69 Million AUD | 52.39% |
2021 Q4 | 8.69 Million AUD | 0.0% |
2021 Q2 | 6.23 Million AUD | 0.0% |
2020 FY | 5.7 Million AUD | -16.08% |
2020 Q2 | 6.67 Million AUD | 0.0% |
2020 Q4 | 5.7 Million AUD | 0.0% |
2019 Q2 | 4.78 Million AUD | 0.0% |
2019 Q4 | 6.79 Million AUD | 0.0% |
2019 FY | 6.79 Million AUD | 17.88% |
2018 FY | 5.76 Million AUD | 3.95% |
2018 Q4 | 5.76 Million AUD | 0.0% |
2018 Q2 | 4.59 Million AUD | 0.0% |
2017 Q4 | 5.54 Million AUD | 0.0% |
2017 Q2 | 5.2 Million AUD | 0.0% |
2017 FY | 5.54 Million AUD | 4.33% |
2016 FY | 5.31 Million AUD | 72.6% |
2016 Q4 | 5.31 Million AUD | 0.0% |
2016 Q2 | 3.87 Million AUD | 0.0% |
2015 FY | 3.08 Million AUD | 115.99% |
2015 Q2 | 2.74 Million AUD | 0.0% |
2015 Q4 | 3.08 Million AUD | 0.0% |
2014 Q4 | 1.42 Million AUD | 0.0% |
2014 FY | 1.42 Million AUD | 12.28% |
2014 Q2 | 1.46 Million AUD | 0.0% |
2013 Q2 | 1.13 Million AUD | 0.0% |
2013 Q4 | 1.27 Million AUD | 0.0% |
2013 FY | 1.27 Million AUD | -44.88% |
2012 Q4 | 2.3 Million AUD | 0.0% |
2012 FY | 2.3 Million AUD | 8.58% |
2011 FY | 2.12 Million AUD | -20.82% |
2011 Q4 | 2.12 Million AUD | 0.0% |
2010 Q4 | 2.68 Million AUD | 0.0% |
2010 FY | 2.68 Million AUD | -11.58% |
2009 Q4 | 3.03 Million AUD | 0.0% |
2009 FY | 3.03 Million AUD | 36.85% |
2008 FY | 2.21 Million AUD | -7.16% |
2008 Q4 | 2.21 Million AUD | 0.0% |
2007 FY | 2.38 Million AUD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
4DMedical Limited | 49.08 Million AUD | 87.282% |
Adherium Limited | 3.4 Million AUD | -83.253% |
Aroa Biosurgery Limited | 14.77 Million AUD | 57.757% |
Atomo Diagnostics Limited | 1.29 Million AUD | -382.311% |
Anteris Technologies Ltd | 17.03 Million AUD | 63.361% |
Control Bionics Limited | 2.75 Million AUD | -126.228% |
CardieX Limited | 8.56 Million AUD | 27.087% |
Compumedics Limited | 22.14 Million AUD | 71.812% |
Cochlear Limited | 904.6 Million AUD | 99.31% |
CleanSpace Holdings Limited | 6.94 Million AUD | 10.169% |
Cyclopharm Limited | 13.65 Million AUD | 54.28% |
EMVision Medical Devices Ltd | 5.45 Million AUD | -14.432% |
Nova Eye Medical Limited | 8.55 Million AUD | 27.0% |
HeraMED Limited | 1.5 Million AUD | -314.559% |
Imricor Medical Systems, Inc. | 25 Million AUD | 75.032% |
InhaleRx Limited | 911.41 Thousand AUD | -584.98% |
LBT Innovations Limited | 5.5 Million AUD | -13.344% |
Micro-X Limited | 12.63 Million AUD | 50.586% |
Neurotech International Limited | 314.69 Thousand AUD | -1883.8% |
OncoSil Medical Limited | 1.98 Million AUD | -214.986% |
PolyNovo Limited | 37.04 Million AUD | 83.147% |
Respiri Limited | 3.55 Million AUD | -75.662% |
SomnoMed Limited | 24.78 Million AUD | 74.807% |
Universal Biosensors, Inc. | 10.61 Million AUD | 41.173% |
Uscom Limited | 2.07 Million AUD | -201.074% |
Visioneering Technologies, Inc. | 2.76 Million AUD | -125.631% |